Enfusion, Inc.
ENFN

$1 B
Marketcap
$10.63
Share price
Country
$0.16
Change (1 day)
$11.38
Year High
$7.52
Year Low

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.

marketcap

P/B ratio for Enfusion, Inc. (ENFN)

P/B ratio as of 2023: 15.94

According to Enfusion, Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 15.94. At the end of 2022 the company had a P/B ratio of 12.70.

P/B ratio history for Enfusion, Inc. from 2019 to 2023

P/B ratio at the end of each year

Year P/B ratio
2023 15.94
2022 12.70
2021 24.84
2020 -9.59
2019 -19.00